- May 14, 2025
With her kids in school and ambitions to become a nurse practitioner, the George Mason nursing student is charting her path with purpose
- May 9, 2025
Rocío Rodríguez Morales, MSW ‘25, a first-generation student, found support and community at George Mason as she forged a new career path with her third degree.
- May 8, 2025
Pilot grants fund interdisciplinary faculty research on prevention, community impact, and clinical innovation
- April 16, 2025
This year at the college's annual National Public Health Week “Conversations and Connections” event, experts explore the health consequences of isolation—and our collective responsibility to address it.
- April 11, 2025
After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.